Family · Pharmaceutical analytical standards
Bilastine
A second-generation H1 antihistamine developed in Spain, authorised in Europe in 2010 and first launched in Spain in 2011, for allergic rhinoconjunctivitis and urticaria. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It is practically not metabolised and does not interact with cytochrome P450 enzymes; PET studies show that it occupies very few H1 receptors in the brain.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
